# Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

> **NCT00122590** · NA · TERMINATED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 115 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** nelfinavir
- **DRUG:** lopinavir/r
- **DRUG:** indinavir
- **DRUG:** ritonavir

## Key facts

- **NCT ID:** NCT00122590
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 115 (—)
- **Last updated:** 2005-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122590, "Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00122590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*